Steven Cohen Exact Sciences Corp Transaction History

Point72 Asset Management, L.P.

$36 Billion
Q2 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Exact Sciences Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 195,770 shares of EXAS stock, worth $10.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

195,770

Previous 195,770 -0.0%

Holding current value

$10.4 Million

Previous $8.27 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$41.33 - $74.26 $73.3 Million - $132 Million	-1,774,004 Reduced 90.06%	195,770 $8.27 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $38.3 Million - $50.2 Million	680,583 Added 52.79%	1,969,774 $136 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $54.4 Million - $69.8 Million	921,740 Added 250.85%	1,289,191 $95.4 Million
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $54.3 Million - $81.6 Million	-823,485 Reduced 69.15%	367,451 $25.1 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $18.1 Million - $27.4 Million	-288,361 Reduced 19.49%	1,190,936 $112 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $14.4 Million - $21.6 Million	305,388 Added 26.01%	1,479,297 $100 Million
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $38.2 Million - $66.8 Million	-1,257,002 Reduced 51.71%	1,173,909 $58.1 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $77.7 Million - $120 Million	2,430,911 New	2,430,911 $79 Million
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $858,201 - $1.84 Million	-24,100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $1.39 Million - $1.99 Million	24,100 New	24,100 $1.69 Million
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $1.29 Million - $1.77 Million	-14,299 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $1.34 Million - $1.99 Million	14,299 New	14,299 $1.78 Million
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $14.6 Million - $20.4 Million	-200,200 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $11.2 Million - $18.6 Million	200,200 New	200,200 $17.4 Million
Q3 2019 Nov 15, 2019	SELL	$90.37 - $122.49 $10 Million - $13.6 Million	-110,898 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $9.47 Million - $12.5 Million	105,850 Added 2096.87%	110,898 $13.1 Million
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $5.55 Million - $8.64 Million	-89,552 Reduced 94.66%	5,048 $437,000
Q4 2018 Feb 14, 2019	BUY	$56.04 - $82.66 $5.3 Million - $7.82 Million	94,600 New	94,600 $5.97 Million
Q2 2018 Aug 14, 2018	SELL	$37.84 - $69.96 $21.8 Million - $40.4 Million	-576,800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$39.82 - $57.53 $1.19 Million - $1.73 Million	29,994 Added 5.49%	576,800 $23.3 Million
Q4 2017 Feb 14, 2018	BUY	$46.49 - $60.51 $25.4 Million - $33.1 Million	546,806	546,806 $28.7 Million

Others Institutions Holding EXAS

# of Institutions

651

Shares Held

166M

Call Options Held

1.96M

Put Options Held

1.41M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.42B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account